Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging
- 6 November 2003
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 482 (1-3) , 319-324
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imagingBritish Journal of Pharmacology, 2003
- Pulmonary Inflammation Monitored Noninvasively by MRI in Freely Breathing RatsBiochemical and Biophysical Research Communications, 2002
- Dose-dependent Effects of Inhaled Mometasone Furoate on Airway Function and Inflammation After Allergen Inhalation ChallengeAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway ratsBritish Journal of Pharmacology, 2001
- Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological FunctionsEndocrine Reviews, 2001
- Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the ratBritish Journal of Pharmacology, 2000
- p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic PotentialsPharmacology & Therapeutics, 1999
- The p38 MAP Kinase Pathway and Its Biological FunctionTrends in Cardiovascular Medicine, 1998
- RPR 106541, a novel, airways‐selective glucocorticoid: effects against antigen‐induced CD4+T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lungBritish Journal of Pharmacology, 1997
- Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway ratsJournal of Allergy and Clinical Immunology, 1991